ASPH and acute myeloid leukemia: Studies have demonstrated overexpression of ASPH in the AML cell line MOLM-14 in vitro, and successful targeting of myeloblasts with anti-ASPH radiolabeled or cytotoxin-linked antibody drug-conjugates (ADCs) (28, 29).